Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Collette

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 6, 2012
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trialsCarine A Bellera, Marina Pulido, Sophie Gourgou, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
The Lancet. Oncology|January 16, 2015
Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient dataAnne J Breugom, Marloes Swets, Jean-François Bosset, et al.
European Radiology|January 7, 2021
Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI studyNicolas F Michoux, Jakub W Ceranka, Jef Vandemeulebroucke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2014
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led studySophie Postel-Vinay, Laurence Collette, Xavier Paoletti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2020
Impact of the COVID-19 crisis on imaging in oncological trialsChristophe M Deroose, Frédéric E Lecouvet, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 studyMartin Kocher, Riccardo Soffietti, Ufuk Abacioglu, et al.
Health and Quality of Life Outcomes|May 12, 2017
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerMarieke van Leeuwen, Jacobien M Kieffer, Fabio Efficace, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|November 6, 2012
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trialsCarine A Bellera, Marina Pulido, Sophie Gourgou, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
The Lancet. Oncology|January 16, 2015
Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient dataAnne J Breugom, Marloes Swets, Jean-François Bosset, et al.
European Radiology|January 7, 2021
Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI studyNicolas F Michoux, Jakub W Ceranka, Jef Vandemeulebroucke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2014
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led studySophie Postel-Vinay, Laurence Collette, Xavier Paoletti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2020
Impact of the COVID-19 crisis on imaging in oncological trialsChristophe M Deroose, Frédéric E Lecouvet, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 studyMartin Kocher, Riccardo Soffietti, Ufuk Abacioglu, et al.
Health and Quality of Life Outcomes|May 12, 2017
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerMarieke van Leeuwen, Jacobien M Kieffer, Fabio Efficace, et al.
Pageof 16